Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy. - Wikidata - wikimedia - TriplyDB

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.

http://www.wikidata.org/entity/Q40180989

about

Regenerating proteins and their expression, regulation, and signaling Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literature The role of Reg IV in colorectal cancer, as a potential therapeutic target Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer The reg4 gene, amplified in the early stages of pancreatic cancer development, is a promising therapeutic target Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer.Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior.REG4 independently predicts better prognosis in non-mucinous colorectal cancer.Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer.Reg IV is a direct target of intestinal transcriptional factor CDX2 in gastric cancer RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.Proteomic and metabolic prediction of response to therapy in gastric cancer.The role of the REG4 gene and its encoding product in ovarian epithelial carcinoma REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker.Serum concentration and expression of Reg IV in patients with esophageal cancer: Age-related elevation of serum Reg IV concentration.Proteomic profiling of paraffin-embedded samples identifies metaplasia-specific and early-stage gastric cancer biomarkers.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel.Regulation of multidrug resistance 1 expression by CDX2 in ovarian mucinous adenocarcinoma.Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma REG Iα gene expression is linked with the poor prognosis of lung adenocarcinoma and squamous cell carcinoma patients via discrete mechanisms.The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers.New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives.Significance of regenerating islet-derived type IV gene expression in gastroenterological cancers RETRACTED: Screening of key genes in gastric cancer with DNA microarray analysis.Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.REGIV as a potential biomarker for peritoneal dissemination in gastric adenocarcinoma.Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer.Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.Regenerating islet-derived family member, 4 modulates multiple receptor tyrosine kinases and mediators of drug resistance in cancer.Serial analysis of gene expression of esophageal squamous cell carcinoma: ADAMTS16 is upregulated in esophageal squamous cell carcinoma.Regenerating Family Member 4 (Reg4) Enhances 5-Fluorouracil Resistance of Gastric Cancer Through Activating MAPK/Erk/Bim Signaling Pathway.Abnormal growth factor/cytokine network in gastric cancer PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.Glycosylation-related gene expression in HT29-MTX-E12 cells upon infection by Helicobacter pylori.Expression profile of REG family proteins REG Ialpha and REG IV in advanced gastric cancer: comparison with mucin phenotype and prognostic markers.Enhanced RegIV expression predicts the intrinsic 5-fluorouracil (5-FU) resistance in advanced gastric cancer.

P2860

Q24625407-D307BCB0-1396-44E4-8056-D1404D21D193 Q26741242-F2D9220F-33EA-40B8-8AE7-EDBD442F936C Q26777750-8609CCCA-03A5-4884-9E87-4C1AC036A948 Q26825103-6608BBC3-50E4-4CB0-B93E-3923199D7694 Q26830780-1915B3F5-225F-41A3-A6A1-37F69CE9FD6E Q33510943-27FCFBB3-9B4B-40EB-A6FF-D1490CFCFDD3 Q33700623-F04EBDA1-2FB8-4E15-A8EE-91495E1D9D67 Q33873519-A217A9EB-D93C-499A-94C0-0A3FA210225D Q34308855-CB445BDE-F1CB-4E9C-8178-9C34378C7622 Q34309021-8B2B5316-CD67-4C59-8415-205E66774F1A Q34401768-3D5C3525-8179-421D-B586-0E57889E2795 Q34469547-6E96397D-C7FC-48F4-BA11-DC4A7E9FC271 Q35095334-0811252A-5F85-4943-AFB9-4B450D62A04A Q35336183-7131735A-288C-4351-B8F9-71EDDE0A2571 Q35664633-0D211008-E30D-4F81-B327-1CE9DFAB2477 Q35959074-133F6D8F-C12A-4CAA-9515-FB0C3ED1B900 Q36135787-60C3498B-A568-4187-8014-43BF5E1B2173 Q36355626-22E740D7-1837-45C0-BB04-3A912EF84F86 Q36687528-2E7F1722-AA90-443C-950D-62C9ED441A6F Q36936018-197D1AE1-F706-4960-A2ED-1ACDC3567155 Q37094927-4A827F3B-65BC-4026-AA7E-E354CCC716D4 Q37185241-4FF1BA28-D932-45A2-AD3E-2526EB8E7E1F Q37341352-33A0A623-AECF-435D-97B0-69270797AE0F Q37448891-FC17CFD9-17B4-4EBE-87D7-CADA94F49A5D Q37537123-ED382340-6B3A-41EB-8063-6E7373791C03 Q37725910-D3DDCF72-73C0-4F88-8688-22DA5C7297BD Q38028939-101E6036-057F-4466-BEE4-A0C18E82BDDC Q38312158-8944AC4C-825A-493B-AE4D-F8AEC9A69986 Q38316610-CA747D5C-CD16-4CB5-A96C-8F4E66D244E5 Q38472134-F2E7195A-620B-41A6-84D5-90E245682F7A Q39101622-E2A8A5D3-4E2D-4CC8-874E-749D34CEFE38 Q39376769-616BE359-1B1F-4E7D-8E99-EDC370C8F009 Q39568944-C8F9CACE-F315-49E7-8FE4-39348B8DBA9F Q39744311-7040A465-239B-4496-986D-59F966E9673E Q40101289-299E9331-14B2-45A8-AEAC-5F2FEEA056B4 Q41990869-154A8ABB-810B-45C9-8AD6-A4F1A15BC30C Q46856111-CBC15914-00E1-40C2-9620-826CEAE07813 Q47140622-2ABFD9AD-A174-4849-B548-91E0BAA8B181 Q51746168-7DE01026-E1B5-42E2-9B8C-8DAE4E44AB5D Q54290367-56D18D4F-03D0-4E7C-9131-59704DAF7597

P2860

Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy.

http://www.wikidata.org/entity/Q40180989

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Reg IV is a serum biomarker fo ...... uorouracil-based chemotherapy.

@en

type

label

Reg IV is a serum biomarker fo ...... uorouracil-based chemotherapy.

@en

prefLabel

Reg IV is a serum biomarker fo ...... uorouracil-based chemotherapy.

@en

P1433

Q40180989-1EE5753E-A80A-4C51-8904-5F2CE6B34BB6

P1476

Q40180989-7618170B-D257-457C-8699-05EA1D7DF41F

P2093

Q40180989-032F6C1C-2174-47C9-8A98-E3D0EFAF1C8C

Q40180989-0F148D96-D357-41E7-BD05-F2ED5CCBA19D

Q40180989-4D24C52A-3A1B-46BF-BF2E-164C748F8E4C

Q40180989-5D4DB8EC-FFC0-4A01-8F1B-8A91CAB47046

Q40180989-9DEA0D10-32F8-4A36-B257-3AEAE4B5B9BE

Q40180989-B45B9F6F-27D6-4BCE-A58F-1B5BCAA612B8

Q40180989-C27C9B1F-9811-47FF-B3F0-DA8472CEF78F

Q40180989-C54E6523-F3CE-4A30-949F-CF485A90E1E6

Q40180989-D18FE96D-F66D-4F03-A508-CD391F2C4C9D

Q40180989-E74C4F15-3E50-4702-94DA-760627F2B3EF

P2860

Q40180989-81B775AF-4212-4B85-BD11-EDEF8CE14388

Q40180989-9244CBD0-9002-4680-812D-DF843560509C

P2888

Q40180989-497C238B-6FE8-486C-BC6F-B374DD406170

P304

Q40180989-C9D4E67F-A625-4417-AD9D-05DDDDC7E208

P31

Q40180989-A53E4506-5BAF-4005-B459-2FFDB02D2FB5

P356

Q40180989-914D6A06-2046-4892-A6CB-5F8D34DD3501

P407

Q40180989-841E4DDD-5044-47E3-8B57-742736B199CE

P433

Q40180989-6C0515A8-DF76-4349-AF2A-D1C30AA3192A

P478

Q40180989-64865D0C-022B-4E1A-A77C-E3BDE9A6BA05

P577

Q40180989-AA94CC11-7212-4DF9-AB34-1C9CD79B1159

P5875

Q40180989-FCF45449-8D84-4E61-BF55-4E84ABD7764F

P6179

Q40180989-711C69D6-C8A2-4CB0-9BB4-429788282E7C

P698

Q40180989-E3EE9A03-F9FF-414B-A6F7-47FAA4045FD8

P921

Q40180989-90C40538-2018-4C85-A0FC-93E640B4DEE0

Q40180989-D1079CC3-7596-488B-9E40-2CD8542703AE

P356

P1433

P1476

Reg IV is a serum biomarker fo ...... uorouracil-based chemotherapy.

@en

P2093

Ito M

http://www.w3.org/2001/XMLSchema#string

Kamata N

http://www.w3.org/2001/XMLSchema#string

Kuniyasu H

http://www.w3.org/2001/XMLSchema#string

Matsumura S

http://www.w3.org/2001/XMLSchema#string

Mitani Y

http://www.w3.org/2001/XMLSchema#string

Noguchi T

http://www.w3.org/2001/XMLSchema#string

Oue N

http://www.w3.org/2001/XMLSchema#string

Tanaka S

http://www.w3.org/2001/XMLSchema#string

Yasui W

http://www.w3.org/2001/XMLSchema#string

Yoshida K

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and characterization of a cDNA encoding a novel member of the human regenerating protein family: Reg IV.

Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.

P2888

P304

4383-4393

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1210215

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6564872

http://www.w3.org/2001/XMLSchema#string

P6179

1006617900

http://www.w3.org/2001/XMLSchema#string

P698

17237819

http://www.w3.org/2001/XMLSchema#string

P921